New Approaches to the Adjuvant Therapy of Colon Cancer
Open Access
- 1 October 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 11 (9) , 973-980
- https://doi.org/10.1634/theoncologist.11-9-973
Abstract
Learning Objectives: After completing this course, the reader will be able to: Discuss clinical trial and SEER data for patients with stage II colon cancer and describe the impact of adjuvant therapy.Discuss clinical trial data supporting the use of adjuvant therapy for stage III colon cancer, including recent trial results with oxaliplatin and irinotecan.Discuss whether stage II colon cancer patients should receive adjuvant chemotherapy and describe the new clinical trial design that integrates molecular marker data. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 35 references indexed in Scilit:
- Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancerEuropean Journal Of Cancer, 2005
- Adjuvant Therapy in Stage II Colon Cancer: Current ApproachesThe Oncologist, 2005
- A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerAnnals of Oncology, 2005
- Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site GroupJournal of Clinical Oncology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon CancerJournal of Clinical Oncology, 2002
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2001
- National Surgical Adjuvant Breast and Bowel Project trials in colon cancerSeminars in Oncology, 2001
- Should Dukes' B patients receive adjuvant therapy? A statistical perspectiveSeminars in Oncology, 2001